Brokerage firm William Blair Upgrades its rating on Markel Corporation(NYSE:MKL). The shares have been rated Outperform. Previously, the analysts had a Market Perform rating on the shares. The rating by William Blair was issued on Apr 14, 2016.
Markel Corporation (MKL) made into the market gainers list on Mondays trading session with the shares advancing 0.72% or 6.6 points. Due to strong positive momentum, the stock ended at $917.18, which is also near the day’s high of $919.7499. The stock began the session at $908.85 and the volume stood at 20,143 shares. The 52-week high of the shares is $937.91 and the 52 week low is $736.96. The company has a current market capitalization of $12,805 M and it has 1,39,61,293 shares in outstanding.
Markel Corporation(MKL) last announced its earnings results on Feb 10, 2016 for Fiscal Year 2015 and Q4.Company reported revenue of $1.42B. Analysts had an estimated revenue of $1.33B. Earnings per share were $14.14. Analysts had estimated an EPS of $7.21.
Several Insider Transactions has been reported to the SEC. On Mar 14, 2016, Darrell D Martin (director) sold 1,000 shares at $890.00 per share price.Also, On Mar 14, 2016, Alan I Kirshner (Executive Chairman) purchased 1 shares at $862.50 per share price.On Feb 25, 2016, Bradley James Kiscaden (EVP & Chief Actuarial Officer) sold 350 shares at $850.52 per share price, according to the Form-4 filing with the securities and exchange commission.
Markel Corporation is a financial holding company serving variety of markets. The Company markets and underwrites specialty insurance products. The Company also owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace. The Company operates in three segments: U.S. Insurance International Insurance and Reinsurance. The U.S. Insurance segment includes all direct business and facultative placements written by the Company’s insurance subsidiaries domiciled in the United States. The International Insurance segment includes all direct business and facultative placements written by the Company’s insurance subsidiaries domiciled outside of the United States including the Company’s syndicate at Lloyd’s. The Reinsurance segment includes all treaty reinsurance written across the Company. In the United States it writes business in the excess and surplus lines (E&S) and specialty admitted insurance and reinsurance markets.